Dietary supplement considerations during GLP-1 treatment: A narrative review

Cropped closeup shot of bowl full of oat cereals with berries for breakfast. Healthy eating habits, dietary meal food concept. Body shaping fitting

Review Highlights Nutritional Strategies to Support Health During GLP-1 Treatment

This narrative review examines nutritional considerations during treatment with GLP-1 receptor agonists (GLP-1RAs), medications increasingly used for obesity and weight management. Researchers note that while these therapies can lead to significant weight loss, nutritional guidance for patients is still evolving.

The review found that targeted dietary supplements may help support health during GLP-1RA treatment. Multivitamins may help address nutrient gaps. Protein supplements may help preserve lean muscle mass during weight loss. Fiber and probiotics may support digestive health and improve bowel regularity.

Researchers also highlighted potential benefits from creatine, β-Hydroxy β-Methylbutyrate (HMB), and antioxidant and anti-inflammatory nutrients. Key takeaways include the importance of adequate protein intake, resistance training, muscle preservation, and digestive support. The authors concluded that combining strategic nutrition support with GLP-1RA therapy may help improve long-term health outcomes during obesity treatment.

Related Resources

Learn more about dietary fiber.

Read the study.

Explore More

Dietary fiber is an important part of a healthy eating pattern and can help support a healthier blood sugar response after meals.‎
Two-year study finds non-nutritive sweetened beverages support greater weight loss than water.
Scientists, regulatory authorities and professional health organizations have extensively ‎evaluated Erythritol. See their statements.
Scientists, regulatory authorities and professional health organizations have extensively ‎evaluated Ace-K. See their statements.
European Food Safety Authority reaffirms safety of aspartame, ace-k and aspartame–acesulfame salt, citing is no safety concern at the reported uses and use levels.
A conference presentation on unpublished science should not outweigh decades of scientific evidence. CCC responds to a recent study on xylitol.